On the Difference Between Designing Children and Raising Them: Ethics and the Use of Educationally Oriented Biotechnology

Mind, Brain, and Education

Volumn 4, Issue 2, 2010, Pages 53-67

  Stein, Zachary ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954059162     PISSN: 17512271     EISSN: 1751228X     Source Type: Journal    
DOI: 10.1111/j.1751-228X.2010.01085.x     Document Type: Article

References (117)

1. Amaral O. Psychiatric disorders as social constructions: ADHD as a case in point. American Journal of Psychiatry 2007, 164:1612-1613.
2. Diagnostic and statistical manual of mental disorders (DSM III-R) 1994, American Psychiatric Association, (4th ed.), (revised)., Washington, DC, American Psychiatric Press
3. Angell M. The truth about drug companies 2003, New York, Random House
4. Nicomachean ethics 2002, Aristotle, (R. Crisp, Trans.)., Cambridge, UK, Cambridge University Press
5. Barondes S H. Better than Prozac: Creating the next generation of psychiatric drugs 2003, New York, Oxford University Press
6. Baldwin J M. Mental development in the child and the race 1895, New York, Macmillan
7. Baldwin J M. Thought and things: A study in the development of meaning and thought or genetic logic 1911, (Vol. 1-4)., New York, Macmillan
8. Braun J, Kahn R, Froehlich T, Auinger P, Lanphear B P. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environmental Health Perspectives 2006, 114:1904-1909.
9. Buchanan A, Brock D W, Daniels N, Wilker D. From chance to choice: Genetics and justice 2000, Cambridge, UK, Cambridge University Press
10. Carey W. What the multimodal treatment study of children with attention deficit disorder did and did not say about the use of methylphenidate for attention defects. Pediatrics 2000, 105:863-864.
11. Conrad P. The medicalization of society: On the transformation of human conditions into treatable disorders 2007, Baltimore, Johns Hopkins University Press
12. Conrad L, Neve M, Nutton V, Porter R, Wear A. The western medical tradition 1995, Cambridge, UK, Cambridge University Press
13. Chandler A. Shaping the industrial century: The remarkable story of the evolution of the modern chemical and pharmaceutical industries 2005, Cambridge, MA, Harvard University Press
14. Chamberland S, Robbins T, Sahakian B. The neurobiology of Attention Deficit Disorder. Biological Psychiatry 2007, 61:1217-1219.
15. Cremin L. American education: The colonial experience, 1607-1783 1970, New York, Harper and Row
16. Cremin L. Public education 1976, New York, Basic Books
17. Cremin L. American education: The metropolitan experience, 1876-1989 1988, New York, Harper and Row
18. Dewey J. Democracy and education 1916, New York, Macmillan
19. Dewey J. The sources of a science of education 1929, New York, Liveright
20. Dewey J. From absolutism to experimentalism. Contemporary American philosophy: Personal statements 1930, 13-27. Adams G PMontague W P. (Eds.),, (Vol. 2, pp., New York, Macmillan
21. Diller L. Running on Ritalin: A physician reflects on children, society, and performance In a pill 1998, New York, Bantam Books
22. Diller L. The last normal child: Essays on the intersection of kids, culture, and psychiatric drugs 2006, Westport, CT, Praeger
23. Elgin C. Considered judgment 1996, Princeton, NJ, Princeton University Press
24. Elliot C. Better than well: American medicine meets the American dream 2003, New York, W.W. Norton & Co
25. Engel G L. The need for a new medical model: A challenge to biomedicine. Science 1977, 196(4286):129-136.
26. Feinberg J. Freedom and fulfillment. Philosophical essays 1992, Princeton, NJ, Princeton University Press
27. Fischer K W. A theory of cognitive development: The control and construction of hierarchies of skills. Psychological Review 1980, 87:477-531.
28. Fischer K W. Mind, brain, and education: Building a scientific groundwork for learning and teaching. Mind, Brain, and Education 2009, 3:3-16.
29. Fischer K W, Bidell T. Dynamic development of psychological structures in action and thought. Handbook of child psychology: Theoretical models of human development 2006, 1-62. Damon W, Lerner R. (Eds.),, (Vol. 1, pp., New York, Wiley
30. Fukuyama F. Our posthuman future: Consequences of the biotechnology revolution 2002, New York, Farrar, Straus, and Giroux
31. Foucault M. Madness and civilization 1961, London, Routledge
32. Glover J. Choosing children: The ethical dilemmas of genetic intervention 2006, New York, Oxford University Press
33. Grigorenko E L. The first candidate gene for dyslexia: Turning the page of a new chapter of research. Proceedings of the National Academy of Sciences 2003, 100:11190-11192.
34. Grigorenko E L. How can genomics inform education? Mind, Brain, and Education 2007, 1:20-27.
35. Habermas J. Communication and the evolution of society 1979, Boston, Beacon Press
36. Habermas J. The theory of communicative action: Reason and the rationalization of society 1984, (Vol. 1)., Boston, Beacon Press
37. Habermas J. The theory of communicative action: Lifeworld and system, a critique of functionalist reason 1987, (Vol. 2)., Boston, Beacon Press
38. Habermas J. Moral consciousness and communicative action 1990, Cambridge, MA, MIT Press
39. Habermas J. Between facts and norms: Contributions to a discourse theory of law and democracy 1996, Cambridge, MA, MIT Press
40. Habermas J. The future of human nature 2003, Cambridge, UK, Polity Press
41. Habermas J. The language game of responsible agency and the problem of free will: How can epistemic dualism be reconciled with ontological monism? Philosophical Explorations 2007, 10:13-50.
42. Harris J. Enhancements are a moral obligation. Human enhancement 2009, Bostrom NSavulescu J. (Eds.),, New York, Oxford University Press
43. Healy D. Psychopharmacology and the new industrial state. Psychotropic drug development: Social economic and pharmacological aspects 1996, Healy DDoogan D. (Eds.),, New York, Chapman & Hall Medical
44. Healy D. The antidepressant era 1997, Cambridge, MA, Harvard University Press
45. Healy D. The creation of psychopharmacology 2002, Cambridge, MA, Harvard University Press
46. Heidegger M. The question concerning technology and other essays 1954/1982, New York, Harper Perennial
47. Herzberg D. Happy pills in America: From Miltown to Prozac 2009, Baltimore, Johns Hopkins University Press
48. Hinshaw S. Externalizing behavior problems and academic underachievement in childhood and adolescence: Causal relationships and underlying mechanisms. Psychological Bulletin 1992, 111:127-155.
49. Hyman S. Ethical issues in pharmacological research and practice. Neuroethics: Mapping the field 2002, Marcus S J. (Ed.),, New York, DANA Press
50. Hyman S. Can neuroscience be integrated into the DSM-V? Nature Reviews Neuroscience 2007, 8:725-732.
51. Illich I. Limits to medicine 1977, New York, Penguin Books
52. Jensen P S, Hinshaw S P, Swanson J M, Greenhill L L, Conners C K, Arnold L E. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics 2001, 22:60-73.
53. Jensen P, Knapp P, Mrazek D. Toward a new diagnostic system for child psychopathology: Moving beyond the DSM 2006, New York, Guilford
54. Kagan J. The three cultures: Natural sciences, social sciences, and the humanities in the 21st century 2009, New York, Cambridge University Press
55. Kant I. The critique of practical reason 1788/1996, (Gregor & Wood, Trans.)., New York, Cambridge University Press
56. Kress E. Beyond the DSM story 2005, Thousand Oaks, CA, Sage
57. Li D, Sham P, Owen M, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Human Molecular Genetics 2006, 15:2276-2284.
58. Liebanua J. Medical science and medical industry 1987, Baltimore, Johns Hopkins University Press
59. Loe I, Feldman H. Academic and educational outcomes of children with ADHD. Journal of Pediatric Psychology 2007, 32:643-654.
60. Marx K. Selected writings 1994, Indianapolis, Hackett Publishing
61. Mareschal D, Johnson M, Sirois S, Spratling M, Thomas M, Westermann G. Neuroconstructivism 2007, (Vol. 1-2)., Oxford, UK, Oxford University Press
62. Mayes R, Bagwell C, Erkulwater J. Medicating children: ADHD and pediatric mental health 2009, Cambridge, MA, Harvard University Press
63. Nigg J T, Goldsmith H H, Sachek J. Temperament and attention deficit/hyperactivity disorder: The development of a multiple pathway model. Journal of Clinical Child and Adolescent Psychology 2004, 33:42-53.
64. Nozick R. Anarchy, state, and utopia 1974, New York, Basic Books
65. Nussbaum M. Cultivating humanity: A classical defense of reform in liberal education 1998, Cambridge, MA, Harvard University Press
66. Nussbaum M. Women and human development: The capabilities approach 2000, New York, Cambridge University Press
67. Nussbaum M. Upheavals of thought: The intelligence of emotions 2001, New York, Cambridge University Press
68. Nussbaum M. Frontiers of justice: Disability, nationality, species membership 2006, Cambridge, MA, Harvard University Press
69. The quality of life 1993, Nussbaum MSen A. (Eds.). (, New York, Oxford University Press
70. Clones and clones: Facts and fantasies about human cloning 1998, Nussbaum MSunstein C. (Eds.). (, New York, W. W. Norton & Company
71. No child left different 2006, Olfman S. (Ed.). (, Westport, CT, Praeger
72. Olfson M, Marcus S C, Weissman M M, Jensen P S. National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:514-521.
73. Overton W F. A coherent introduction to systems philosophy-toward a new paradigm of contemporary thought. Metatheory for dynamic systems: Relational organicism-contextualism. Human Development 2007, 50:154-159.
74. Parens E, Johnston J. Understanding the agreements and controversies surrounding childhood psychopharmacology. Child and Adolescent Psychiatry and Mental Health 2008, 2(5).
75. Parens E, Johnston J. Facts, values, and attention-deficit hyperactivity disorder (ADHD): An update on the controversies. Child and Adolescent Psychiatry and Mental Health 2009, 3(1).
76. Pastor P, Reuben C. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital Health Statistics 2008, 10(237). National Center for Health Statistics
77. Pavlov I P. Conditional reflexes 1927, New York, Dover Publications
78. Pelham W, Foster E, Robb J. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Journal of Pediatric Psychology 2007, 32:711-727.
79. Piaget J. Biology and knowledge 1967/1971, Chicago, University of Chicago Press
80. Plomin R, Kovas Y, Haworth C M A. Generalist genes: Genetic links between brain, mind, and education. Mind, Brain, and Education 2007, 1:11-19.
81. Powell K. Neuro development: How does the teenage brain work. Nature 2006, 442:865-867.
82. Rasmussen N. On speed: The many lives of amphetamine 2007, New York, New York University Press
83. Rawls J. A theory of justice 1971, Cambridge, MA, Harvard University Press
84. Sadler J. Values and psychiatric diagnosis 2005, New York, Oxford University Press
85. Safer D, Zito M, Fine E. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996, 98:1084-1088.
86. Santosh P J, Taylor E, Swanson J, Wigal T, Chuang S, Davies M. Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clinical Neuroscience Research 2005, 5:295-306.
87. Sax L, Kautz R. Who first suggest the diagnosis of attention-deficit/hyperactivity disorder? Annals of Family Medicine 2003, 1:171-174.
88. Scanlon T M. What we owe to each other 1998, Cambridge, MA, Harvard University Press
89. Schore A. Forward to Bowlby's attachment and loss. Attachment and loss: Attachment 1999, Bowlby J. (Ed.),, (Vol. 1)., New York, Basic Books
90. Scheffler R M, Hinshaw S P, Modrek S, Levine P. The global market for ADHD medications. Health Affairs 2007, 26:450-457.
91. Schneider H, Eisenberg D. Who receives a diagnosis of attention-deficit/hyperactivity disorder in the United States elementary school population? Pediatrics 2006, 117:e601-e609.
92. Seidman L, Valera E, Makris N. Structural brain imaging of attention deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1263-1272.
93. Sellars W. In the space of reasons 2006, Cambridge, MA, Harvard University Press
94. Shonkoff J P. From neurons to neighborhoods: Old and new challenges for developmental behavioral pediatrics. Journal of Developmental Behavioral Pediatrics 2003, 42:70-76.
95. Shorter E. A history of psychiatry: From the asylum to the age of Prozac 1997, New York, Wiley
96. Singh I. Clinical implications of ethical concepts: Moral self-understandings in children taking methylphenidate for ADHD. Clinical Child Psychology and Psychiatry 2007, 12:167-182.
97. Singh I. Beyond polemics: The science and ethics of ADHD. Nature Reviews Neuroscience 2008, 9:957-964.
98. Singh I, Rose N. Biomarkers in psychiatry. Nature 2009, 460:202-207.
99. Skinner B F. The behavior of organisms: An experimental analysis 1938, New York, Appleton-Century-Crofts
100. Skinner B F. Beyond freedom and dignity 1971, New York, Bantam Books
101. Sonuga-Barke E. Causal models of attention-deficit/ hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biological Psychiatry 2005, 57:1231-1238.
102. Swanson J, Kinsbourne M, Nigg J, Lanphear B, Stefanatos G, Volkow N. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychological Review 2007, 17:39-59.
103. Swanson J, Sergeant A, Taylor E, Sonuga-Barke E, Jensen P, Cantwell D. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998, 351:429-433.
104. Stein Z, della Chiesa B, Hinton C, Fischer K. Ethical issues in educational neuroscience: Raising children in a brave new world. Handbook of neuroethics Illes J, Sahakian B J, (in press)., (Eds.),, Oxford, UK, Oxford University Press
105. Szasz T. The myth of mental illness 1961, New York, Hoeber & Harper
106. Tomasello M. The cultural origins of human cognition 1999, Cambridge, MA, Harvard University Press
107. Taylor C. Self-interpreting animals. Human agency and language: Philosophical papers 1985, Taylor C. (Ed.),, Cambridge, UK, Cambridge University Press
108. Taylor C. Sources of the self 1989, Cambridge, MA, Harvard University Press
109. Vygotsky L S. Mind in society 1978, Cambridge, MA, Harvard University Press
110. Convention on the rights of the child. 1989, http://www2.ohchr.org/english/law/crc.htm, United Nations, New York, Retrieved November 15, 2009, from:
111. Warner L. We've got issues: Parents and children in the age of medication 2010, New York, Penguin Books
112. Whitaker R. Mad in America: Bad science, bad medicine, and the enduring mistreatment of the mentally ill 2002, Cambridge, MA, Perseus Publishing
113. Wilber K. Integral psychology 1999, Boston, Shambhala
114. Zito J M, Safer D J, Zuckerman I H, Gardner J F, Soeken K. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatric Services 2005, 56:157-163.
115. Zito J M, Safer D J, DosReis S, Gardner J F, Magder L, Soeken K. Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine 2003, 157:17-25.
116. Zito J M, Safer D J, DosReis S, Gardner J F, Boles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. Journal of the American Medical Association 2000, 283:1025-1030.
117. Zito J M, Safer D J. Recent child phamacoepidemiological findings. Journal of Child and Adolescent Psychopharmacology 2005, 15:5-9.